GDUFA Research Outcomes
BE Methods & Analyses
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to bioequivalence methods and analyses for generic drug products.
-
Advances on Using PBPK Modeling to Support BE Assessment for Oral Products
Wu, Fang
-
A Critical Overview of the Biological Effects of Excipients
Wu, Fang; Tsakalozou, Eleftheria
-
Using PBPK Model to Support Risk Assessment for Oral Products
Wu, Fang
-
Challenges and Opportunities when Using Oral PBPK to Support Risk Assessment and Biowaiver in Regulatory Submissions
Wu, Fang
-
PBPK Absorption Modeling to Support Risk Assessment and Biowaiver for Generic Oral Products
Wu, Fang
-
Regulatory and Scientific Considerations on Characterizations of Complex Polymeric Excipients
Wang, Yan
-
In Vitro Drug Release Testing for Complex Generics: A Bioequivalence Perspective
Wang, Yan
-
Bioequivalence Approaches for Long-Acting Drug Products: Regulatory and Scientific Considerations
Wang, Yan
-
Updates to the Simcyp Simulator’s ADAM / M-ADAM Models
Turner, David
-
Exploiting Dual Solid State PBPK Tools to Assess the Bio(in)equivalence of Tacrolimus Amorphous Formulations with Various Degrees of Crystallization Arising During Storage
Turner, David